EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes

Laura A Onyango, Jiawei Liang

Frontiers in Cellular and Infection Microbiology · 28.05.2024 · 14

DOI: 10.3389/fcimb.2024.1380289 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 28.05.2024. Verfasst von Laura A Onyango und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Trinity Western University, Langley, BC, Canada. Hauptthemen laut MEDLINE: Honey, Staphylococcal Infections, Staphylococcus, Anti-Bacterial Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 186 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The antibiotic resistance (ABR) crisis is an urgent global health priority. Staphylococci are among the problematic bacteria contributing to this emergency owing to their recalcitrance to many clinically important antibiotics. Staphylococcal pathogenesis is further complicated by the presence of small colony variants (SCVs), a bacterial subpopulation displaying atypical characteristics including retarded growth, prolific biofilm formation, heightened antibiotic tolerance, and enhanced intracellular persistence. These capabilities severely impede current chemotherapeutics, resulting in chronic infections, poor patient outcomes, and significant economic burden. Tackling ABR requires alternative measures beyond the conventional options that have dominated treatment regimens over the past 8 decades. Non-antibiotic therapies are gaining interest in this arena, including the use of honey, which despite having ancient therapeutic roots has now been reimagined as an alternative treatment beyond just traditional topical use, to include the treatment of an array of difficult-to-treat staphylococcal infections. This literature review focused on Manuka honey (MH) and its efficacy as an anti-staphylococcal treatment. We summarized the studies that have used this product and the technologies employed to study the antibacterial mechanisms that render MH a suitable agent for the management of problematic staphylococcal infections, including those involving staphylococcal SCVs. We also discussed the status of staphylococcal resistance development to MH and other factors that may impact its efficacy as an alternative therapy to help combat ABR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HoneyStaphylococcal InfectionsStaphylococcusAnti-Bacterial AgentsHumansPhenotypeBiofilmsAnimalsLeptospermumMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Manuka honeyStaphylococciantibiotic resistancecoagulase-negative staphylococcinon-antibiotic therapysmall colony variants

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biology, Trinity Western University, Langley, BC, Canada.

Zitieren

APA

Onyango, L. A., & Liang, J. (2024). Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes. Frontiers in Cellular and Infection Microbiology, 14. https://doi.org/10.3389/fcimb.2024.1380289

Vancouver

Onyango LA, Liang J. Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes. Frontiers in Cellular and Infection Microbiology. 2024;14. doi:10.3389/fcimb.2024.1380289

BibTeX
@article{Onyango2024,
  author = {Onyango, Laura A and Liang, Jiawei},
  title = {Manuka honey as a non-antibiotic alternative against Staphylococcus spp. and their small colony variant (SCVs) phenotypes},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  volume = {14},
  doi = {10.3389/fcimb.2024.1380289}
}
Kostenlos starten →